Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: a strategy to inhibit R5 HIV-1. (Q34922802)

5 August 2017

title

Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: a strategy to inhibit R5 HIV-1. (English)

1 reference

5 August 2017

Alonso Heredia

1

1 reference

5 August 2017

Charles Davis

2

1 reference

5 August 2017

Anthony Amoroso

3

1 reference

5 August 2017

Joyelle K Dominique

4

1 reference

5 August 2017

Nhut Le

5

1 reference

5 August 2017

Erin Klingebiel

6

1 reference

5 August 2017

Elise Reardon

7

1 reference

5 August 2017

Davide Zella

8

1 reference

5 August 2017

Robert R Redfield

9

1 reference

5 August 2017

language of work or name

English

0 references

publication date

18 March 2003

1 reference

Proceedings of the National Academy of Sciences of the United States of America

5 August 2017

published in

1 reference

5 August 2017

volume

100

1 reference

5 August 2017

issue

7

1 reference

5 August 2017

page(s)

4179-4184

1 reference

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of the cell cycle

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

ATP-site directed inhibitors of cyclin-dependent kinases.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

C-C chemokines, pivotal in protection against HIV type 1 infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Long-term suppression of HIV-1 by hydroxyurea and didanosine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=153068

Antigen-specific production of RANTES, macrophage inflammatory protein (MIP)-1alpha, and MIP-1beta in vitro is a correlate of reduced human immunodeficiency virus burden in vivo

8 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0630584100

Chemokines: leucocyte recruitment and activation cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0630584100

Resistance to human immunodeficiency virus type 1 in vitro as a surrogate of vaccine-induced protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0630584100

Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0630584100

Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0630584100

Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0630584100

Increased beta-chemokine production in peripheral blood mononuclear cells derived from HIV-1-infected individuals by a cationic amphiphilic drug (AY 9944) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0630584100

Inhibition of sterol and DNA synthesis in peripheral blood lymphocytes by AY9944

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0630584100

1-year follow-up of the use of hydroxycarbamide and didanosine in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0630584100

Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0630584100

21 January 2018

Identifiers

DOI

10.1073/PNAS.0630584100

1 reference

5 August 2017

0 references

1 reference

5 August 2017

1 reference